Patents by Inventor Phil Knowles

Phil Knowles has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Topical compositions comprising polyunsaturated fatty acids
    Patent number: 10918614
    Abstract: The present invention provides a compound which is a polyunsaturated fatty acid (PUFA) derivative of formula (I), or a pharmaceutically acceptable salt, or solvate thereof, for use in treating various skin disorders.
    Type: Grant
    Filed: June 24, 2019
    Date of Patent: February 16, 2021
    Inventors: Adam Kelliher, Angus Morrison, Phil Knowles
  • TOPICAL COMPOSITIONS COMPRISING POLYUNSATURATED FATTY ACIDS
    Publication number: 20190314317
    Abstract: The present invention provides a compound which is a polyunsaturated fatty acid (PUFA) derivative of formula (I), or a pharmaceutically acceptable salt, or solvate thereof, for use in treating various skin disorders.
    Type: Application
    Filed: June 24, 2019
    Publication date: October 17, 2019
    Inventors: Adam Kelliher, Angus Morrison, Phil Knowles
  • Topical compositions comprising polyunsaturated fatty acids
    Patent number: 10328046
    Abstract: The present invention provides a compound which is a polyunsaturated fatty acid (PUFA) derivative of formula (I), or a pharmaceutically acceptable salt, or solvate thereof, for use in treating various skin disorders.
    Type: Grant
    Filed: December 28, 2017
    Date of Patent: June 25, 2019
    Assignee: DS Biopharma Limited
    Inventors: Adam Kelliher, Angus Morrison, Phil Knowles
  • TOPICAL COMPOSITIONS COMPRISING POLYUNSATURATED FATTY ACIDS
    Publication number: 20180116991
    Abstract: The present invention provides a compound which is a polyunsaturated fatty acid (PUFA) derivative of formula (I), or a pharmaceutically acceptable salt, or solvate thereof, for use in treating various skin disorders.
    Type: Application
    Filed: December 28, 2017
    Publication date: May 3, 2018
    Inventors: Adam Kelliher, Angus Morrison, Phil Knowles
  • Topical compositions comprising polyunsaturated fatty acids
    Patent number: 9889106
    Abstract: The present invention provides a compound which is a polyunsaturated fatty acid (PUFA) derivative of formula (I), or a pharmaceutically acceptable salt, or solvate thereof, for use in treating various skin disorders.
    Type: Grant
    Filed: July 18, 2016
    Date of Patent: February 13, 2018
    Assignee: DS BIOPHARMA LIMITED
    Inventors: Adam Kelliher, Angus Morrison, Phil Knowles
  • USE OF PUFAS FOR TREATING SKIN INFLAMMATION
    Publication number: 20160324819
    Abstract: The present invention provides a compound which is a polyunsaturated fatty acid (PUFA) derivative of formula (I), or a pharmaceutically acceptable salt, or solvate thereof, for use in treating various skin disorders.
    Type: Application
    Filed: July 18, 2016
    Publication date: November 10, 2016
    Inventors: Adam Kelliher, Angus Morrison, Phil Knowles
  • Use of pufas for treating skin inflammation
    Patent number: 9439850
    Abstract: The present invention provides a compound which is a polyunsaturated fatty acid (PUFA) derivative of formula (I), or a pharmaceutically acceptable salt, or solvate thereof, for use in treating various skin disorders.
    Type: Grant
    Filed: March 11, 2014
    Date of Patent: September 13, 2016
    Assignee: Dignity Sciences Limited
    Inventors: Adam Kelliher, Angus Morrison, Phil Knowles
  • Topical compositions comprising polyunsaturated fatty acids
    Patent number: 9421163
    Abstract: The present disclosure provides topical compositions comprising a polyunsaturated fatty acid (PUFA) derivative of formula (I): or a salt thereof.
    Type: Grant
    Filed: November 20, 2014
    Date of Patent: August 23, 2016
    Assignee: Dignity Sciences Limited
    Inventors: Adam Kelliher, Angus Morrison, Phil Knowles
  • Use of PUFAS for treating skin inflammation
    Patent number: 9216151
    Abstract: The present invention provides a compound which is a polyunsaturated fatty acid (PUFA) derivative of formula (I), or a pharmaceutically acceptable salt, or solvate thereof, for use in treating various skin disorders.
    Type: Grant
    Filed: June 26, 2014
    Date of Patent: December 22, 2015
    Assignee: Dignity Sciences Limited.
    Inventors: Adam Kelliher, Angus Morrison, Phil Knowles
  • Process for preparing and purifying fatty acids
    Patent number: 9079847
    Abstract: There is provided a process for purifying a fatty acid, which process comprises reacting a fatty acid with a lithium salt in a first solution and under conditions to allow formation of a precipitate of a lithium salt of the fatty acid; isolating the precipitate; dissolving the precipitate in a second solution followed by separation of the organic and aqueous layers so formed; and evaporating the organic layer to isolate the purified fatty acid. There is also provided a process for increasing the length of a fatty acid, and the use of a lithium salt to purify a fatty acid.
    Type: Grant
    Filed: January 27, 2011
    Date of Patent: July 14, 2015
    Assignee: BASF PHARMA (CALLANISH) LIMITED
    Inventors: Adam Kelliher, Angus Morrison, Phil Knowles
  • TOPICAL COMPOSITIONS COMPRISING POLYUNSATURATED FATTY ACIDS
    Publication number: 20150164842
    Abstract: The present disclosure provides topical compositions comprising a polyunsaturated fatty acid (PUFA) derivative of formula (I): or a salt thereof.
    Type: Application
    Filed: November 20, 2014
    Publication date: June 18, 2015
    Inventors: Adam Kelliher, Angus Morrison, Phil Knowles
  • USE OF PUFAS FOR TREATING SKIN INFLAMMATION
    Publication number: 20140309304
    Abstract: The present invention provides a compound which is a polyunsaturated fatty acid (PUFA) derivative of formula (I), or a pharmaceutically acceptable salt, or solvate thereof, for use in treating various skin disorders.
    Type: Application
    Filed: June 26, 2014
    Publication date: October 16, 2014
    Inventors: Adam Kelliher, Angus Morrison, Phil Knowles
  • USE OF PUFAS FOR TREATING SKIN INFLAMMATION
    Publication number: 20140194399
    Abstract: The present invention provides a compound which is a polyunsaturated fatty acid (PUFA) derivative of formula (I), or a pharmaceutically acceptable salt, or solvate thereof, for use in treating various skin disorders.
    Type: Application
    Filed: March 11, 2014
    Publication date: July 10, 2014
    Applicant: DIGNITY SCIENCES LIMITED
    Inventors: Adam Kelliher, Angus Morrison, Phil Knowles
  • Use of pufas for treating skin inflammation
    Patent number: 8729126
    Abstract: The present invention provides a compound which is a polyunsaturated fatty acid (PUFA) derivative of formula (I), or a pharmaceutically acceptable salt, or solvate thereof, for use in treating various skin disorders.
    Type: Grant
    Filed: May 1, 2012
    Date of Patent: May 20, 2014
    Assignee: Dignity Sciences Limited
    Inventors: Adam Kelliher, Angus Morrison, Phil Knowles
  • Use of PUFAs for treating skin inflammation
    Patent number: 8536223
    Abstract: The present invention provides a compound which is a polyunsaturated fatty acid (PUFA) derivative of formula (I), or a pharmaceutically acceptable salt, or solvate thereof, for use in treating various skin disorders.
    Type: Grant
    Filed: April 29, 2010
    Date of Patent: September 17, 2013
    Assignee: Dignity Sciences Limited
    Inventors: Adam Kelliher, Angus Morrison, Phil Knowles
  • PROCESS FOR PREPARING AND PURIFYING FATTY ACIDS
    Publication number: 20130150602
    Abstract: There is provided a process for purifying a fatty acid, which process comprises reacting a fatty acid with a lithium salt in a first solution and under conditions to allow formation of a precipitate of a lithium salt of the fatty acid; isolating the precipitate; dissolving the precipitate in a second solution followed by separation of the organic and aqueous layers so formed; and evaporating the organic layer to isolate the purified fatty acid. There is also provided a process for increasing the length of a fatty acid, and the use of a lithium salt to purify a fatty acid.
    Type: Application
    Filed: January 27, 2011
    Publication date: June 13, 2013
    Applicant: BASF PHARMA (CALLANISH) LIMITED
    Inventors: Adam Kelliher, Angus Morrison, Phil Knowles
  • USE OF PUFAS FOR TREATING SKIN INFLAMMATION
    Publication number: 20120213824
    Abstract: The present invention provides a compound which is a polyunsaturated fatty acid (PUFA) derivative of formula (I), or a pharmaceutically acceptable salt, or solvate thereof, for use in treating various skin disorders.
    Type: Application
    Filed: May 1, 2012
    Publication date: August 23, 2012
    Applicant: DIGNITY SCIENCES LIMITED
    Inventors: Adam Kelliher, Angus Morrison, Phil Knowles
  • USE OF PUFAS FOR TREATING SKIN INFLAMMATION
    Publication number: 20120142773
    Abstract: The present invention provides a compound which is a polyunsaturated fatty acid (PUFA) derivative of formula (I), or a pharmaceutically acceptable salt, or solvate thereof, for use in treating various skin disorders.
    Type: Application
    Filed: April 29, 2010
    Publication date: June 7, 2012
    Applicant: DIGNITY SCIENCES LIMITED
    Inventors: Adam Kelliher, Angus Morrison, Phil Knowles
  • USE OF PUFAS TO TREAT NERVE DAMAGE
    Publication number: 20120122982
    Abstract: The present invention provides use of compounds which are polyunsaturated fatty acid (PUFA) derivatives of formula (I), in the form of racemates, stereoisomers or mixtures of stereoisomers, or pharmaceutically acceptable salts, or solvates thereof, wherein -AIk- is —(CH2)4—CH(OR2)-[trans]CH?CH-[cis]CH?CH—, —(CH2)4-[cis]CH?CH-[trans]CH?CH—CH(OR2)—, —CH(OR2)-[trans]CH?CH-[cis]CH?CH—CH2-[cis]CH?CH—(CH2)3—, —(CH2)3—CH(OR2)-[trans]CH?CH-[cis]CH?CH—CH2-[cis]CH?CH—, or —(CH2)3-[cis]CH?CH—CH2-[cis]CH?CH-[trans]CH?CH—CH(OR2)—; R1 is a hydrogen atom; or R1 is a C1-C6 alkyl, C2-C6 alkenyl, C2-C6 alkynyl, C6-C10 aryl, 5- to 10-membered heteroaryl, C3-C7 carbocyclyl or 5- to 10-membered heterocyclyl group; or R1 is a group of formula —CH2—CH(OR3)—CH2—(OR4), wherein R3 and R4 are each independently hydrogen atoms or —(C?O)—R6, wherein R6 is an aliphatic group having from 3 to 29 carbon atoms; or R1 is a group of formula —(CH2OCH2)mOH, wherein m is an integer of from 1 to 200; or R1 is a drug moiety; each R2 is the-same or
    Type: Application
    Filed: April 22, 2010
    Publication date: May 17, 2012
    Applicant: Equateq Limited
    Inventors: Adam Kelliher, Norman Camaron, Angus Morrison, Phil Knowles